This proposal includes 10 funded Cores including: A) Administration, B) Development, which funded 17 NIAs since 1994, C) Biostatistics, which coordinates access to a UW HIV/AIDS biostatistics team; D) Clinical Research, funded several pilot grants leading to funded research and will collaborate with other cores to establish an HIV Specimen Repository Subcore; and will sponsor pilot grants for use of this repository and of Core G clinical data base; E) International Research, has coordinated research in over 50 developing countries over the past 5 years and will begin a new Subcore for HIV/AIDS Research in Women and Children; F) Clinical Retrovirology, expanded its BSL-3 space, introduced new technologies, and will initiate a new Molecular Pathology Virology Subcore; G) Health Services Research, supports longitudinal studies of problems in health care delivery and outcomes research; H) Genomics, a new core, will support genomics and bioinformatics research; I) Molecular Immunology - which developed methods for analyzing the cellular immune response to HIV, has introduced a BSL-3 flow cytometry/cell-sorting subcore; a tetramer assay subcore; and a humoral immunity subcore. Both Core H and Core I will add BIACORE facilities, for complementary, non duplicative uses; and J) SocioBehavioral and Prevention Research a new core, added due to increasing numbers of behavioral and prevention research expertise at the UW. Strategic planning for HIV/AIDS program development resulted in 180,000 sq. ft. of new or renovated space for CFAR members at the UW, including FHCRC and HMC, CHRMC, and SBRI. Ongoing strategic planning for the CFAR has been led by the Directors and the Executive Committee; guided by the new National CFAR Program Mission, and by our own CFAR theme emphasizing translational and interdisciplinary research; by assessment of strengths, needs, and opportunities represented by funded research programs and by perceptions of CFAR members; by recommendations from our External Advisory Committee, and by help from our Internal Advisory.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
2P30AI027757-16
Application #
6602190
Study Section
Special Emphasis Panel (ZAI1-EC-A (J1))
Program Officer
Namkung, Ann S
Project Start
1988-09-30
Project End
2008-02-29
Budget Start
2003-03-01
Budget End
2004-02-29
Support Year
16
Fiscal Year
2003
Total Cost
$1,599,589
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Wilson, Kate S; Wanje, George; Masese, Linnet et al. (2018) A Prospective Cohort Study of Fertility Desire, Unprotected Sex, and Detectable Viral Load in HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 78:276-282
Ikoma, Minako; Gantt, Soren; Casper, Corey et al. (2018) KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite. PLoS One 13:e0192659
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
Thomson, Kerry A; Dhanireddy, Shireesha; Andrasik, Michele et al. (2018) Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. AIDS Care 30:121-129
Lohman-Payne, Barbara; Gabriel, Benjamin; Park, Sangshin et al. (2018) HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med 7:26
McGrath, Christine J; Singa, Benson; Langat, Agnes et al. (2018) Non-disclosure to male partners and incomplete PMTCT regimens associated with higher risk of mother-to-child HIV transmission: a national survey in Kenya. AIDS Care 30:765-773
Njuguna, Irene N; Wagner, Anjuli D; Omondi, Vincent O et al. (2018) Financial Incentives for Pediatric HIV Testing in Kenya. Pediatr Infect Dis J 37:1142-1144

Showing the most recent 10 out of 1275 publications